(Q53454509)

English

Synthetic nanoparticle vaccines produced by layer-by-layer assembly of artificial biofilms induce potent protective T-cell and antibody responses in vivo.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20951665

Synthetic nanoparticle vaccines produced by layer-by-layer assembly of artificial biofilms induce potent protective T-cell and antibody responses in vivo. (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20951665

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Thomas J Powell

1

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20951665

Naveen Palath

2

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20951665

Mary E DeRome

3

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20951665

Jie Tang

4

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20951665

Andrea Jacobs

5

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20951665

James G Boyd

6

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20951665

language of work or name

0 references

publication date

15 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20951665

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20951665

29

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20951665

3

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20951665

558-569

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20951665

Multilayers of colloidal particles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Layer-by-layer assembly as a versatile bottom-up nanofabrication technique for exploratory research and realistic application

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Fuzzy Nanoassemblies: Toward Layered Polymeric Multicomposites

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Protein-calcium carbonate coprecipitation: a tool for protein encapsulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Polyelectrolyte films based on polysaccharides of different conformations: effects on multilayer structure and mechanical properties

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Polysaccharide multilayer nanoencapsulation of insulin-producing beta-cells grown as pseudoislets for potential cellular delivery of insulin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Polypeptide multilayer films

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Biomedical applications of electrostatic layer-by-layer nano-assembly of polymers, enzymes, and nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Polypeptide multilayer nanofilm artificial red blood cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Preparation of insulin nanoparticles and their encapsulation with biodegradable polyelectrolytes via the layer-by-layer adsorption

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Novel formulations of vitamins and insulin by nanoengineering of polyelectrolyte multilayers around microcrystals

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Controlled intracellular release of peptides from microcapsules enhances antigen presentation on MHC class I molecules

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Size-dependent immunogenicity: therapeutic and protective properties of nano-vaccines against tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Short peptide sequences containing MHC class I and/or class II epitopes linked to nano-beads induce strong immunity and inhibition of growth of antigen-specific tumour challenge in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Improvement of adaptive immunity by antigen-carrying biodegradable nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Pre-clinical evaluation of a novel nanoemulsion-based hepatitis B mucosal vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Polymer nanoparticles for immunotherapy from encapsulated tumor-associated antigens and whole tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Targeting of antigen to dendritic cells with poly(gamma-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

The effect of poly(D,L-lactide-co-glycolide) microparticles with polyelectrolyte self-assembled multilayer surfaces on the cross-presentation of exogenous antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Straightforward and effective protein encapsulation in polypeptide-based artificial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Stimulated release of small molecules from polyelectrolyte multilayer nanocoatings.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Vaccination with recombinant fusion proteins incorporating Toll-like receptor ligands induces rapid cellular and humoral immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Chloroquine inhibits lysosomal enzyme pinocytosis and enhances lysosomal enzyme secretion by impairing receptor recycling

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Analysis of the effect of amines on inhibition of receptor-mediated and fluid-phase pinocytosis in rabbit alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Toll-like receptor signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Lps genotype in the C57 black mouse background and its influence on the interleukin-6 response to E. coli urinary tract infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Toll-like receptor 4 (TLR4) does not confer a resistance advantage on mice against low-dose aerosol infection with virulent type A Francisella tularensis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Organ-specific regulation of the CD8 T cell response to Listeria monocytogenes infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Immunogenicity of heterologous prime-boost regimens involving recombinant adenovirus serotype 11 (Ad11) and Ad35 vaccine vectors in the presence of anti-ad5 immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

CD8+ T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Depletion of CD4+ T cells during immunization with nonviable Listeria monocytogenes causes enhanced CD8+ T cell-mediated protection against listeriosis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Poly-L-lysine-coated nanoparticles: a potent delivery system to enhance DNA vaccine efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Cell-free tumor antigen peptide-based cancer vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

"Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Regulation of phagosome maturation by signals from toll-like receptors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

On regulation of phagosome maturation and antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Toll-dependent selection of microbial antigens for presentation by dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Inflammasome-activating nanoparticles as modular systems for optimizing vaccine efficacy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Structure-based design of peptides that self-assemble into regular polyhedral nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Peptide nanoparticles serve as a powerful platform for the immunogenic display of poorly antigenic actin determinants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Peptide nanoparticles as novel immunogens: design and analysis of a prototypic severe acute respiratory syndrome vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Prime-boost vaccination with plasmid DNA and a chimeric adenovirus type 5 vector with type 35 fiber induces protective immunity against HIV.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Potent specific immune responses induced by prime-boost-boost strategies based on DNA, adenovirus, and Sendai virus vectors expressing gag gene of Chinese HIV-1 subtype B.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Physics of polypeptide multilayer films

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Design of peptides for thin films, coatings and microcapsules for applications in biotechnology.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

A paradigm for peptide vaccine delivery using viral epitopes encapsulated in degradable polymer hydrogel capsules

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

A Protective Vaccine Delivery System for In Vivo T Cell Stimulation Using Nanoengineered Polymer Hydrogel Capsules

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Biodegradable polyelectrolyte microcapsules: antigen delivery tools with Th17 skewing activity after pulmonary delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

Adjuvant Effects of Low Doses of a Nuclease-Resistant Derivative of Polyinosinic Acid · Polycytidylic Acid on Antibody Responses of Monkeys to Inactivated Venezuelan Equine Encephalomyelitis Virus Vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on adjuvants for human prophylactics. I. Comparison of efficiencies of different adjuvants at various stages of immunization with tetanus and diphtheria toxoids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.10.001

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2010.10.001

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20951665

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 May 2018

http://europepmc.org/abstract/MED/20951665

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53454509&oldid=1382133704"